The Ketoconazole 1%/Salicylic Acid 10% Topical Solution is a liquid formulation designed for external application to the skin. This solution combines the antifungal properties of ketoconazole with the keratolytic effects of salicylic acid, providing a targeted treatment for various dermatological conditions.
It is primarily used to treat seborrheic dermatitis, dandruff, and psoriasis. The formulation effectively addresses fungal infections while promoting the shedding of dead skin cells, thereby alleviating symptoms and improving skin health.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Ketoconazole 1%/Salicylic Acid 10% Topical Solution is a compounded medication formulated for external application to the skin. This liquid solution provides a convenient and versatile means of delivering active ingredients directly to affected areas, offering targeted treatment for various dermatological conditions.
The combination of ketoconazole and salicylic acid in this topical solution offers a synergistic approach to skin therapy. Ketoconazole is an antifungal agent that works by inhibiting the growth of fungi by altering the permeability of the fungal cell membrane.
Salicylic acid, present at a concentration of 10%, acts as a keratolytic agent. It helps to exfoliate the skin by softening and shedding the outer layer of dead skin cells.
This compounded topical solution is particularly beneficial for conditions where fungal infections and hyperkeratosis coexist. By removing the excess keratin, salicylic acid enhances the penetration of ketoconazole into the skin, improving its antifungal efficacy. The liquid formulation allows for easy application over large or hairy areas and ensures uniform distribution of the active ingredients.
For prescribers, this medication offers a customizable option for patients who may not respond adequately to standard treatments. It can be tailored to the individual needs of patients, adjusting concentrations if necessary under professional guidance. It is essential to consider the patient's medical history, potential allergies, and concurrent medications when prescribing this formulation.
Patients using Ketoconazole 1%/Salicylic Acid 10% Topical
Ketoconazole 1%/Salicylic Acid 10% Topical Solution is a compounded formulation designed for the treatment of various dermatological conditions, including fungal infections, seborrheic dermatitis, and psoriasis. This combination leverages the antifungal properties of ketoconazole and the keratolytic effects of salicylic acid to provide a comprehensive approach to skin treatment. However, it is important to consider potential drug interactions when using this topical solution to ensure safety and efficacy.
Ketoconazole, an imidazole antifungal agent, works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes. While primarily used topically, systemic absorption can occur, especially when applied over large surface areas or under occlusive dressings. This absorption can potentially lead to interactions with other medications metabolized by the cytochrome P450 enzyme system, particularly CYP3A4. Patients using oral or systemic medications that are substrates, inhibitors, or inducers of CYP3A4 should be monitored for potential interactions. Examples include certain statins, anticoagulants like warfarin, and some immunosuppressants. Although the risk is lower with topical application, caution is advised, especially in patients with liver impairment or those using multiple medications.
Salicylic acid, a beta-hydroxy acid, aids in the exfoliation of the stratum corneum, enhancing the penetration of ketoconazole and other topical agents. While systemic absorption of salicylic acid from topical application is generally minimal, it can increase when applied to large areas, broken skin, or under occlusion. This can potentially lead to salicylate toxicity, particularly in patients with renal impairment or those concurrently using systemic salicylates or other medications that can increase serum salicylate levels. Symptoms of salicylate toxicity include tinnitus, dizziness, and metabolic acidosis, and patients should be advised to report any unusual symptoms promptly.
Patients should be informed about the potential for local skin reactions, such as irritation, dryness, or contact dermatitis, which may be exacerbated by the keratolytic action of salicylic acid. Concurrent use of other topical products, especially those containing alcohol or other irritants, should be approached with caution to avoid compounding these effects. Additionally, the use of other topical antifungals or keratolytics should be discussed with a healthcare provider to prevent overuse or adverse reactions.
For prescribers, it is crucial to evaluate the patient's complete medication profile, including over-the-counter products and supplements, to identify potential interactions. Consideration should be given to the patient's overall health status, including liver and kidney function, to tailor the treatment plan appropriately. Monitoring for adverse effects and therapeutic outcomes should be part of the ongoing management strategy.
If you have any questions or need further information regarding the use of Ketoconazole 1%/Salicylic Acid 10% Topical Solution, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any concerns or inquiries you may have.
The Ketoconazole 1%/Salicylic Acid 10% Topical Solution is a specialized liquid formulation designed for external application to the skin, offering a targeted approach to treating various dermatological conditions. This formulation combines the antifungal properties of ketoconazole with the keratolytic effects of salicylic acid, providing a comprehensive treatment option for conditions such as seborrheic dermatitis, dandruff, and certain fungal skin infections.
Ketoconazole is an imidazole antifungal agent that works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. By disrupting the cell membrane, ketoconazole effectively impairs the growth and replication of fungi, making it a potent treatment for fungal infections. Its inclusion in this formulation helps to address the underlying fungal component often present in conditions like seborrheic dermatitis and dandruff, reducing symptoms such as itching, flaking, and inflammation.
Salicylic acid, on the other hand, is a beta-hydroxy acid known for its keratolytic properties. It works by softening and loosening the keratin in the skin, promoting the shedding of dead skin cells and reducing scaling. This action not only helps to alleviate the visible symptoms of scaling and flaking but also enhances the penetration of ketoconazole into the affected areas, improving its efficacy. Salicylic acid's ability to exfoliate the skin also aids in unclogging pores and reducing the buildup of sebum, which can be beneficial in managing conditions like dandruff and seborrheic dermatitis.
The liquid formulation of this topical solution allows for easy application and absorption, ensuring that the active ingredients are delivered directly to the affected areas. This targeted delivery system maximizes the therapeutic effects while minimizing potential side effects. Patients and prescribers can appreciate the versatility of this formulation, as it can be applied to various areas of the body, including the scalp, face, and other skin regions affected by dermatological conditions.
For patients, it is important to follow the prescribed application instructions to achieve optimal results. Typically, the solution should be applied to clean, dry skin, and left to dry before covering the area with clothing or other products. Consistent use as directed by a healthcare provider will help in managing symptoms effectively and preventing recurrence.
Prescribers considering this formulation for their patients should evaluate the specific dermatological condition and the patient's medical history to ensure suitability. The combination of ketoconazole and salicylic acid offers a dual-action approach that can be particularly beneficial for patients with mixed fungal and keratotic conditions.
If you have any questions or need further information about the Ketoconazole 1%/Salicylic Acid 10% Topical Solution, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have.
This topical solution is used to treat various dermatological conditions, such as fungal infections, dandruff, and seborrheic dermatitis. Ketoconazole is an antifungal agent, while salicylic acid helps to exfoliate the skin and reduce scaling.
Apply the solution to the affected area of the skin as directed by your healthcare provider. Ensure the area is clean and dry before application. Avoid contact with eyes, mouth, and other mucous membranes.
Consult your healthcare provider before using this solution on your face, as the skin on the face can be more sensitive. They can provide guidance on appropriate use and precautions.
The frequency of application will depend on the specific condition being treated and your healthcare provider's instructions. Typically, it may be applied once or twice daily, but follow your provider's recommendations.
Some users may experience mild irritation, redness, or dryness at the application site. If you experience severe irritation or an allergic reaction, discontinue use and contact your healthcare provider.
If you are pregnant or breastfeeding, consult your healthcare provider before using this topical solution to ensure it is safe for you and your baby.
Store the solution at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
Before using this solution with other topical medications, consult your healthcare provider to avoid potential interactions or increased irritation.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
This solution may not be suitable for all skin types, especially sensitive skin. It is important to consult your healthcare provider to determine if it is appropriate for your specific skin type and condition.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)